Pellicori, P., Ofstad, A. P., Fitchett, D., Zeller, C., Wanner, C., George, J., . . . Lindenfeld, J. (2020). Early benefits of empagliflozin in patients with or without heart failure: Findings from EMPA-REG OUTCOME. ESC heart failure, 7(6), . https://doi.org/10.1002/ehf2.12891
Chicago Style (17th ed.) CitationPellicori, Pierpaolo, Anne Pernille Ofstad, David Fitchett, Cordula Zeller, Christoph Wanner, Jyothis George, Bernard Zinman, Martina Brückmann, and JoAnn Lindenfeld. "Early Benefits of Empagliflozin in Patients with or Without Heart Failure: Findings from EMPA-REG OUTCOME." ESC Heart Failure 7, no. 6 (2020). https://doi.org/10.1002/ehf2.12891.
MLA (9th ed.) CitationPellicori, Pierpaolo, et al. "Early Benefits of Empagliflozin in Patients with or Without Heart Failure: Findings from EMPA-REG OUTCOME." ESC Heart Failure, vol. 7, no. 6, 2020, https://doi.org/10.1002/ehf2.12891.